Evidence map›Paper›PMID 27910188›Full record

ArticleAddiction biology2018

Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.

Steven J Simmons, Ryan A Gregg, Fionya H Tran, Lili Mo, Eva von Weltin, David J Barker, Taylor A Gentile, Lucas R Watterson, Scott M Rawls, John W Muschamp

Abstract readComparative Study
In one paragraph

Article in Addiction biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Steven J SimmonsCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Ryan A GreggCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Fionya H TranCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Lili MoCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Eva von WeltinCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
David J BarkerNational Institute on Drug Abuse, Neuronal Networks Section, National Institutes of Health, USA.
Taylor A GentileCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Lucas R WattersonCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Scott M RawlsCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
John W MuschampCenter for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, USA.
Temple University · USNational Institute on Drug Abuse · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6M
Psychoactive bath salts and the glutamate systemR01DA039139 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI RAWLS, SCOTT M. · 2015 to 2019
$1.8M
Role of orexin (hypocretin) in impulsive behaviorR00DA031767 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI MUSCHAMP, JOHN W · 2014 to 2016
$741k
NIDA NIH HHS P30 DA013429NIDA NIH HHS R00 DA031767NIDA NIH HHS R01 DA039139NIDA NIH HHS T32 DA007237
6 · The paper itself

Abstract

Abuse of synthetic psychostimulants like synthetic cathinones has risen in recent years. 3,4-Methylenedioxypyrovalerone (MDPV) is one such synthetic cathinone that demonstrates a mechanism of action similar to cocaine. Compared to cocaine, MDPV is more potent at blocking dopamine and norepinephrine reuptake and is readily self-administered by rodents. The present study compared the rewarding and reinforcing properties of MDPV and cocaine using systemic injection dose-response and self-administration models. Fifty kilohertz ultrasonic vocalizations (USVs) were recorded as an index of positive affect throughout experiments. In Experiment 1, MDPV and cocaine dose-dependently elicited 50-kHz USVs upon systemic injection, but MDPV increased USVs at greater rates and with greater persistence relative to cocaine. In Experiment 2, latency to begin MDPV self-administration was shorter than latency to begin cocaine self-administration, and self-administered MDPV elicited greater and more persistent rates of 50-kHz USVs versus cocaine. MDPV-elicited 50-kHz USVs were sustained over the course of drug load-up whereas cocaine-elicited USVs waned following initial infusions. Notably, we observed a robust presence of context-elicited 50-kHz USVs from both MDPV and cocaine self-administering rats. Collectively, these data suggest that MDPV has powerfully rewarding and reinforcing effects relative to cocaine at one-tenth doses. Consistent with prior work, we additionally interpret these data in supporting that MDPV has significant abuse risk based on its potency and subjectively positive effects. Future studies will be needed to better refine therapeutic strategies targeted at reducing the rewarding effects of cathinone analogs in efforts to ultimately reduce abuse liability.

Indexed as

RewardAnimalsBenzodioxolesCocaineDopamine Uptake InhibitorsMalePyrrolidinesRatsReinforcement, PsychologySelf AdministrationSynthetic CathinoneUltrasonic WavesVocalization, AnimalBenzodioxolesCocaineDopamine Uptake InhibitorsPyrrolidinesSynthetic Cathinone3,4-methylenedioxypyrovaleroneaffectcocaineself-administrationsynthetic cathinoneultrasonic vocalizations

Identifiers

PMID27910188
PMCPMC5453848
OpenAlexW2558282764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.